Hospice: what to do when anti-cancer therapy is no longer appropriate, effective, or desired
Kinzbrunner, B.M.
Seminars in Oncology 21(6): 792-798
1994
ISSN/ISBN: 0093-7754 PMID: 7527597 Document Number: 425225
Document emailed within 1 workday
Related Documents
Pawuk, L.G.; Schumacher, J.E. 2010: Introducing music therapy in hospice and palliative care: an overview of one hospice's experience Home Healthcare Nurse 28(1): 37-44Stula, N. 1992: Adjuvant cytostatic therapy of breast cancer as an important factor in the postponing of a relapse and longer survival period Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 46(2): 101-111
Ong, J.; Brennsteiner, A.; Chow, E.; Hebert, R.S. 2016: Correlates of Family Satisfaction with Hospice Care: General Inpatient Hospice Care versus Routine Home Hospice Care Journal of Palliative Medicine 19(1): 97-100
Germain, M.J.; Cohen, L.M.; Moss, A.H. 2007: Strategies for timely and effective hospice discussions: end-stage renal disease Annals of Internal Medicine 147(11): 816; Author Reply 817
Meissner, T. 2003: Diabetes: education more effective than drugs? those who know more, live longer MMW Fortschritte der Medizin 145(20): 14
Seagroatt, V. 1997: Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Paper's main conclusion is no longer justified when data from all trials are considered Bmj 315(7109): 677; Author Reply 678-9
Adamus, G.; Arendt, A.; Zam, Z.S.; McDowell, J.H.; Hargrave, P.A. 1988: Use of peptides to select for anti-rhodopsin antibodies with desired amino acid sequence specificities Peptide Research 1(1): 42-47
Römisch, J.; Stöhr, H.A.; Stauss, H.; Koschinsky, R.; Stüber, W.; Pâques, E.P. 1994: Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide Thrombosis and Haemostasis 71(3): 320-324
Woodall, H.E.; Dennis, W. 2003: Comfort always. the Rainey Hospice House: South Carolina's first inpatient hospice Journal of the South Carolina Medical Association 99(8): 224-226
Lageder, H. 1975: Desired and undesired effects of fasting therapy Hippokrates 46(1): 70-85
Gavrilov, V.; Steiner, M.; Shany, S. 2005: The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth Anticancer Research 25(5): 3425-3429
2006: Novel combined therapy for prostate cancer proves significantly more effective Oncology 20(7): 785
Winkfield, K.M.; Harris, J.R. 2009: Effective local therapy and long-term survival in breast cancer Oncology 23(8): 669-675
Watanabe, S.; Mayama, M.; Oguro, M.; Wakatsuki, S.; Majima, H. 1990: A markedly effective combination therapy of 5'-DFUR and MMC in advanced gastric cancer--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(10): 2105-2108
Hamblin, T.J. 1991: Interleukin-2 for anti-cancer therapy Comprehensive Therapy 17(12): 35-38
Tanizaki, K.; Nishioka, K.; Kobayashi, K.; Igarashi, Y.; Tsukao, Y.; Tanida, T.; Komori, T.; Matsumoto, T.; Takachi, K.; Aoki, T.; Uemura, Y. 2008: A case of AFP producing gastric cancer for which radiation therapy was effective in paraaortic lymph node recurrence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(12): 2048-2050
Asagawa, T.; Ishii, H.; Kobashi, K.; Tsunemitsu, K.; Itou, M.; Ninomiya, H.; Higaki, R.; Miyazaki, F.; Murakami, M.; Noguchi, T. 2008: CR obtained by CPT-11 and CDDP combination-therapy in a small-cell lung-cancer patient through effective pharmaceutical care Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(6): 961-964
Ecker-Schlipf, B. 1994: Anti-hormonal therapy in breast cancer Medizinische Monatsschrift für Pharmazeuten 17(8): 247-250
Taira, T.; Yamamoto, N. 2012: Anti-VEGF therapy for lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2159-2164
Chen, D.; Carter, T.H.; Auborn, K.J. 2004: Apoptosis in cervical cancer cells: implications for adjunct anti-estrogen therapy for cervical cancer Anticancer Research 24(5a): 2649-2656